Cargando…
Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming
Cardiovascular disease, until now, is still the leading cause of death in the United States. Due to the limited regenerative capacity of adult hearts, the damage caused by heart injury cannot be reversed and eventually progress into heart failure. In need of cardiovascular disease treatment, many th...
Autores principales: | Tang, Yawen, Zhao, Lianzhong, Yu, Xufen, Zhang, Jianyi, Qian, Li, Jin, Jian, Lu, Rui, Zhou, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238038/ https://www.ncbi.nlm.nih.gov/pubmed/34087994 http://dx.doi.org/10.1016/j.scr.2021.102365 |
Ejemplares similares
-
Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis
por: Delgado-Olguín, Paul, et al.
Publicado: (2012) -
TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming
por: Tang, Yawen, et al.
Publicado: (2022) -
EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
por: Pang, Bo, et al.
Publicado: (2016) -
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration
por: Chen, Olivia, et al.
Publicado: (2015) -
Molecular barriers to direct cardiac reprogramming
por: Vaseghi, Haley, et al.
Publicado: (2017)